Dr. Joshua Lin, DO

Dr. Lin practices at Emanate Health Foothill Presbyterian Hospital - Mammography in Glendora, California.

Dr. Lin's NPI, 1114289550, was assigned on June 12, 2012. Dr. Lin graduated from WesternU College of Osteopathic Medicine of the Pacific in 2012. Dr. Lin's Virginia license number on file is 0102206189.

Dr. Lin's primary practice is Emanate Health Foothill Presbyterian Hospital - Mammography, at 250 S Grand Ave., Glendora, CA 91741. The practice phone is (626) 857-3118.

Dr. Lin's primary practice is Emanate Health Foothill Presbyterian Hospital - Mammography in Glendora, California. Dr. Lin is also affiliated with Emanate Health Foothill Presbyterian Hospital. The medical group on file is Vituity. Dmand AI also links Dr. Lin to 2 more hospitals, 7 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lin is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lin's licenses on file in 8 states: Virginia, California, Indiana, Missouri, Illinois, Michigan, South Carolina and New York.

Dmand AI lists acute respiratory failure, acute stomach ulcer, cardiac arrhythmia, congestive heart failure, electrolyte disorders, gastrointestinal bleeding, gastrointestinal infection and gastrointestinal inflammation among the conditions Dr. Lin treats.

CMS data shows 306 Medicare services from Dr. Lin across 5 procedure codes in 2024, for 127 Medicare patients. Medicare paid $26,322 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 127 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 68, with 53% women.

In 2024, Dr. Lin wrote 141 Medicare Part D claims for 57 patients. 83% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $84 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Lin for performance year 2024, reported as part of a group. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Lin in 2018. Dr. Lin's most frequent co-authors are Andre Elias Nel, MD and Zev Aryeh Wainberg, MD.

CMS Open Payments shows 13 general payments to Dr. Lin from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $313.

Dr. Lin graduated from WesternU College of Osteopathic Medicine of the Pacific in 2012. Dr. Lin is a member of AOA.

Dr. Lin is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Aetna and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.